Adverse Event Clinical Research
1.0.1 - STU1

Adverse Event Clinical Research, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ae-research-ig/ and changes regularly. See the Directory of published versions

## MedicationAdministration: medication-administration-kadcyla

Page standards status: Informative

Generated Narrative: MedicationAdministration

Resource MedicationAdministration "medication-administration-kadcyla"

status: completed

### Medications

- | Concept
* | KADCYLA (RxNorm#1371046)

subject: Patient/patient-example-kaitlyn-b " BOUNCE"

occurence: 2020-04-01

> performer

> ### Actors

> - | Reference
> * | Practitioner/practitioner-oncology-nurse-jane " NURSE"

request: MedicationRequest/medication-request-example-kadcyla

note: 3.6mg administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/practitioner-oncology-nurse-jane @2020-04-01)

### Dosages

- | Route | Dose
* | Intravenous route (qualifier value) (SNOMED CT#47625008) | 3.6 mg (Details: UCUM code mg = 'mg')